SEC Filing Details
Document Details
Form
Filing Date
Jan 3, 2020
Document Date
01/01/20
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Protalix BioTherapeutics
Issuer
PROTALIX BIOTHERAPEUTICS, INC.
Filer
Melincoff Gwen A